Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dick de Zeeuw

Showing results (11-20 of 394) with videos related to

Pageof 40
Sort By:
Journal of Nephrology|August 5, 2020
The future of Diabetic Kidney Disease management: reducing the unmet needDick de Zeeuw
Kidney International. Supplement|March 2, 2011
Need for better diabetes treatment for improved renal outcomePeter Rossing, Dick de Zeeuw
Diabetes Care|February 15, 2008
Albuminuria: a great risk marker, but an underestimated target in diabetesDick de Zeeuw, Itamar Raz
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2014
New renal guidelines; is more better?Petra Denig, Dick de Zeeuw
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 17, 2009
The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitusMaarten J Postma, Dick de Zeeuw
Kidney International|May 24, 2013
LDL cholesterol in CKD--to treat or not to treat?Ziad A Massy, Dick de Zeeuw
Lancet (London, England)|February 23, 2010
Composite renal endpoints: was ACCOMPLISH accomplished?Hiddo Lambers Heerspink, Dick de Zeeuw
Nature Reviews. Nephrology|October 14, 2015
The glycocalyx--linking albuminuria with renal and cardiovascular diseaseTon J Rabelink, Dick de Zeeuw
Journal of the American Society of Nephrology : JASN|March 13, 2009
Drug dosing for renoprotection: maybe it's time for a drug efficacy-safety score?Dick de Zeeuw, Hiddo Lambers-Heerspink
Nature Reviews. Nephrology|August 25, 2009
Pharmacology: defining the optimal dose of a new drug: a crucial decisionHiddo Lambers Heerspink, Dick de Zeeuw
Pageof 40

Showing results (11-20 of 394) with videos related to

Sort By:
Pageof 40
Journal of Nephrology|August 5, 2020
The future of Diabetic Kidney Disease management: reducing the unmet needDick de Zeeuw
Kidney International. Supplement|March 2, 2011
Need for better diabetes treatment for improved renal outcomePeter Rossing, Dick de Zeeuw
Diabetes Care|February 15, 2008
Albuminuria: a great risk marker, but an underestimated target in diabetesDick de Zeeuw, Itamar Raz
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 23, 2014
New renal guidelines; is more better?Petra Denig, Dick de Zeeuw
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|July 17, 2009
The economic benefits of preventing end-stage renal disease in patients with type 2 diabetes mellitusMaarten J Postma, Dick de Zeeuw
Kidney International|May 24, 2013
LDL cholesterol in CKD--to treat or not to treat?Ziad A Massy, Dick de Zeeuw
Lancet (London, England)|February 23, 2010
Composite renal endpoints: was ACCOMPLISH accomplished?Hiddo Lambers Heerspink, Dick de Zeeuw
Nature Reviews. Nephrology|October 14, 2015
The glycocalyx--linking albuminuria with renal and cardiovascular diseaseTon J Rabelink, Dick de Zeeuw
Journal of the American Society of Nephrology : JASN|March 13, 2009
Drug dosing for renoprotection: maybe it's time for a drug efficacy-safety score?Dick de Zeeuw, Hiddo Lambers-Heerspink
Nature Reviews. Nephrology|August 25, 2009
Pharmacology: defining the optimal dose of a new drug: a crucial decisionHiddo Lambers Heerspink, Dick de Zeeuw
Pageof 40